Recursion Pharmaceuticals Inc (RXRX)
9.42
-0.09
(-0.95%)
USD |
NASDAQ |
May 17, 16:00
9.42
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Assets (Quarterly): 557.85M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 557.85M |
December 31, 2023 | 653.70M |
September 30, 2023 | 630.82M |
June 30, 2023 | 666.70M |
March 31, 2023 | 627.37M |
December 31, 2022 | 701.29M |
September 30, 2022 | 611.53M |
Date | Value |
---|---|
June 30, 2022 | 672.52M |
March 31, 2022 | 734.32M |
December 31, 2021 | 610.34M |
September 30, 2021 | 658.61M |
June 30, 2021 | 698.59M |
March 31, 2021 | 271.94M |
December 31, 2020 | 298.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
271.94M
Minimum
Mar 2021
734.32M
Maximum
Mar 2022
599.58M
Average
642.26M
Median
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 63.94B |
Absci Corp | 274.90M |
Palatin Technologies Inc | 11.41M |
Oragenics Inc | 4.966M |
Actinium Pharmaceuticals Inc | 88.35M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 156.70M |
Shareholders Equity (Quarterly) | 401.15M |
Debt to Equity Ratio | 0.0028 |
Current Ratio | 4.648 |
Net Debt Paydown Yield | -0.00% |